Articles Posted in Defective Medicine

Wyeth Pharmaceuticals Agrees to Pay $490. 9 Million for Marketing the Prescription Drug Rapamune for Unapproved Uses
Borchardt Law Firm Team

Wyeth Pharmaceuticals Inc., (now owned by Pfizer) a pharmaceutical company has agreed to pay $490.9 million to resolve the unlawful marketing of the prescription drug Rapamune. The U.S. Food and Drug Administration (FDA) did not approve it as safe and effective, the Justice Department announced the other day. Rapamune is an “immunosuppressive” drug that prevents…

Continue reading ›
Two Dialysis Drugs Have Been Recalled; Granuflo and Naturalyte
Borchardt Law Firm Team

GranuFlo and Naturalyte are two dialysis products recalled by the Food and Drug Administration. Fresenius Medical Care, the world’s largest provider of dialysis clinics and products, manufactures both GranuFlo and Naturalyte. The FDA has issued a Class 1 recall – the most urgent type of recall – on both products. This recall is reserved for…

Continue reading ›
Benefits of Drugs Outweigh the Risks
Borchardt Law Firm Team

There has been a decent amount of coverage on the prescription drugs Januvia and Byetta. Januvia (sitagliptin) and Byetta are both injectable drugs, and provide a new way of treating type 2 diabetes. They both help control blood sugar levels by encouraging production of a hormone called glucagon-like peptide 1 (GLP-1). They have potential advantages…

Continue reading ›
Diabetes Medications Byetta and Januvia May Be Linked to Pancreatic Complications
Borchardt Law Firm Team

The FDA has recently announced that they will be investigating the safety of several diabetes medications due to some troubling scientific evidence. A group of academic researchers took pancreatic tissue samples from patients who had been taking these diabetes medications found that some of the patients had inflammation and cellular changes that often precede cancer,…

Continue reading ›
Fosamax Manufacturer Pays $285,000 in Osteonecrosis Case
Borchardt Law Firm Team

Merck, the manufacturer of the bone-loss medication Fosamax, has recently been ordered to pay $285,000 to a woman who suffered osteonecrosis (dead jaw) as a result of taking this drug. Reuters reports that the plaintiff suffered from bone disease and delayed healing after a routine tooth extraction. The jury decided in favor of the plaintiff,…

Continue reading ›
Pradaxa Litigation Picking up Speed
Borchardt Law Firm Team

Multidistrict Litigation (MDL) on the problematic drug Pradaxa has been moved up to begin in March of 2014, as opposed to previously scheduled August 2014. There are currently over 175 cases pending in this MDL in Southern Illinois. In preparation for the upcoming proceedings, both the plaintiffs and Boehringer Ingelheim, the manufacturer of the anticoagulant…

Continue reading ›
Yaz Lawsuit Update and New Information About Kidney Stones
Borchardt Law Firm Team

Bayer could have to pay up to or more than $1.2 billion in order to settle personal injury lawsuits over the company’s Yaz and Yasmin oral contraceptives. For Bayer’s second quarter stockholder update, Bayer told its investors that it is currently facing nearly 13,000 Yaz and Yasmin lawsuits. In July 2012, Bayer accepted a settlement…

Continue reading ›
Yaz, Yasmin and Ocella: Time to File Your Claim
Borchardt Law Firm Team

The birth control drugs Yaz, Yasmin and Ocella are facing increasing litigation citing some serious complications. According to the San Francisco Chronicle, a recent study listed Yaz and Yasmin as the second worst drugs on the market for adverse events. Between Yaz and Yasmin alone, over 8,000 adverse side effects were reported to the FDA…

Continue reading ›

Contact Us

  1. 1 Free Initial Consultation
  2. 2 Over 30 Years of Experience
  3. 3 High Quality Representation

Complete the contact form or call us at 800-994-2115 to schedule your free initial consultation.

Fill out the form and we'll respond within 1 Hour during business hours

800-994-2115